Fibroblast markers in labial salivary gland biopsies in progressive systemic sclerosis.
Labial salivary gland (LSG) biopsies from 13 patients were studied. Three were normal glands, five showed fibrosis induced by progressive systemic sclerosis (PSS) and five more had PSS-induced fibrosis combined with and focal sialadenitis compatible with Sjögren's syndrome (SS). Monoclonal antibodies to proline-4-hydroxylase (alpha PH or 5B5-A) and the carboxyterminal domain of human type I procollagen (alpha pC or M-38) were used as fibroblast markers. Immunostaining was done with avidin-biotin-peroxidase complex (ABC). Using various sample controls (including cultured fibroblasts and specimens enriched for lymphocytes, plasma cells, granulocytes, monocytes and dendritic cells) as well as analysis of various LSG resident cells, the specificity of the alpha PH and alpha pC markers for fibroblasts was established. Cross reactions were only seen with plasma cells and acinar cells containing the beta subunit of PH or disulfide isomerase involved in SS-SH interchange reactions in these secretory cells. All fibroblasts in fibroblast monolayer cultures at their logarithmic phase of growth stained with the fibroblast markers studied, but false negative staining was seen with resting, mature fibroblasts in dense connective tissue in LSG sections. Therefore, it can be concluded that proline 4-hydroxylase and the COOH-terminal domain of type-I procollagen both indicate fibroblast involvement in collagen (type l) synthesis and thus identify active but not resting fibroblasts. PH+ fibroblast-like cells and pC+ fibroblasts were both more frequent in PSS LSGs than in normal glands, suggesting active local fibroblast involvement in PSS.(ABSTRACT TRUNCATED AT 250 WORDS)
Janin
A
A
Department of Pathology C, Hopital Calmette, Lille, France.
Konttinen
Y T
YT
Grönblad
M
M
Karhunen
P
P
Gosset
D
D
Malmström
M
M
D000911:Antibodies, Monoclonal / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D003094:Collagen / Q000096:biosynthesis; D005069:Evaluation Studies as Topic; D005347:Fibroblasts / Q000032:analysis* / Q000276:immunology / Q000473:pathology; D005355:Fibrosis; D006801:Humans; D010446:Peptide Fragments / Q000032:analysis* / Q000276:immunology; D011347:Procollagen / Q000032:analysis* / Q000276:immunology; D011393:Procollagen-Proline Dioxygenase / Q000032:analysis* / Q000276:immunology; D012466:Salivary Gland Diseases / Q000473:pathology*; D012469:Salivary Glands / Q000473:pathology*; D012595:Scleroderma, Systemic / Q000150:complications / Q000276:immunology / Q000473:pathology*; D012793:Sialadenitis / Q000209:etiology / Q000276:immunology / Q000473:pathology*; D012859:Sjogren's Syndrome / Q000150:complications / Q000276:immunology / Q000473:pathology
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D010446:Peptide Fragments; D011347:Procollagen; C042813:procollagen type I carboxy terminal peptide; D003094:Collagen; D011393:Procollagen-Proline Dioxygenase